Nathan J. Dowden - Sep 15, 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Operating Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Stock symbol
TRDA
Transactions as of
Sep 15, 2022
Transactions value $
-$1,501
Form type
4
Date filed
9/19/2022, 04:34 PM
Previous filing
Sep 12, 2022
Next filing
Sep 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Sale -$1.5K -100 -0.15% $15.01 68.6K Sep 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.